About | Free Trial

Last Update

2015-12-07T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Philippe Halfon?

Dr. Philippe Halfon

Chief Executive Officer

Genoscience

Direct Phone: +33 *********       

Email: p***@***.com

Genoscience

Marseille, Provence

France

Company Description

Genoscience, a biopharmaceutical company located in Marseille, France, is focused on the development of new drugs for the treatment of viral diseases as HCV. Genoscience's innovative technology platform, which combines internal expertise in resistance wit... more

Find other employees at this company (3)

Background Information

Employment History

Chief Executive Officer
AlphaBio Inc

Affiliations

Founder
ACTGene Inc

Member of - The Company - Scientific Advisory Board
Advanced Biological Laboratories SA

Education

MD

Web References (49 Total References)


Philippe Halfon, MD, PharmD, ...

www.genosciencepharma.com [cached]

Philippe Halfon, MD, PharmD, PhD, President and founder

Dr Halfon is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including ACTgene, Alphabio, and GenosciencePharma. He completed a training in Oncogenetic and continue to have a consultation in oncogenetic and infectious Diseases in the European Hospital. He was recently appointed as Associate Professor in Paris Medical college


Philippe Halfon, MD, PharmD, ...

www.genosciencepharma.com [cached]

Philippe Halfon, MD, PharmD, PhD, President and founder

Dr Halfon is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including ACTgene, Alphabio, and GenosciencePharma. He completed a training in Oncogenetic and continue to have a consultation in oncogenetic and infectious Diseases in the European Hospital. He was recently appointed as Associate Professor in Paris Medical college


management team

www.3dgenoscience.com [cached]

Philippe Halfon, M.D., Ph.D., Pharm.D., founder acting as President CEO Dr. Halfon is presently CEO of Alphabio Laboratory (Marseille, France, 10 ME of revenues) in charge of R&D. He is specialized in molecular virology. Dr. Halfon is a worldwide virological expert for HIV and HBV and acts as a peer-reviewer for virological scientific reviews. Dr. Halfon published more than 100 international publication. Dr. Halfon acted previously as a consultant for Roche Diagnostics, France (1997-2000), and for Schering Plough, France (1998-2005). Dr Halfon is the Chief Scientific Officer and CEO of Genoscience until a CSO is recruited. He is responsible for the scientific validation of the technology through completing retrospective studies and submitting results to major scientific reviews over Q4 2001 and Q1 2002, and participating in international conferences. Dr Halfon is also co-author of the VIRADAPT study, which validated the effectiveness of treatment using resistance testing (genotyping). Dr. Halfon was nominated as one of the 30 best managers in France with Alphabio Laboratory.


Professor Philippe Halfon, ...

www.nimitfinance.com [cached]

Professor Philippe Halfon, world-renowned scientist for his work on HIV, HPV (human papilloma virus causing cervical cancer) and Hepatitis, and a co-inventor of BL-8030, said, "BL-8030 has shown promising results in pre-clinical studies, and may become an important part of combination therapies for HCV.

...
BL-8030 was invented by Professor Philippe Halfon and his team at Genoscience, and co-developed with scientists at RFS Pharma, LLC. Prof. Halfon, Co-Founder and President of Genoscience, is a specialist in molecular virology and infectious diseases, especially HIV, HPV and Hepatitis. In addition he is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including ACTgene, Alphabio and Genoscience.


Professor Philippe Halfon, ...

www.nimitfinance.com [cached]

Professor Philippe Halfon, world-renowned scientist for his work on HIV, HPV (human papilloma virus causing cervical cancer) and Hepatitis, and a co-inventor of BL-8030, said, "BL-8030 has shown promising results in pre-clinical studies, and may become an important part of combination therapies for HCV.

...
BL-8030 was invented by Professor Philippe Halfon and his team at Genoscience, and co-developed with scientists at RFS Pharma, LLC. Prof. Halfon, Co-Founder and President of Genoscience, is a specialist in molecular virology and infectious diseases, especially HIV, HPV and Hepatitis. In addition he is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including ACTgene, Alphabio and Genoscience.

Similar Profiles

Other People with this Name

Other people with the name Halfon

Neal Halfon
UCLA

Galit Halfon
Mamilla Hotel

Eric Halfon
Thomson Reuters

Neal Halfon
Westside Children's Center

Avishai Halfon
Goldfarb Seligman & Co

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory